MDT

86.15

-0.06%↓

A

114.35

-0.27%↓

VEEV

172.96

-0.65%↓

HQY

83.99

+1.05%↑

PHR.US

8.27

-3.61%↓

MDT

86.15

-0.06%↓

A

114.35

-0.27%↓

VEEV

172.96

-0.65%↓

HQY

83.99

+1.05%↑

PHR.US

8.27

-3.61%↓

MDT

86.15

-0.06%↓

A

114.35

-0.27%↓

VEEV

172.96

-0.65%↓

HQY

83.99

+1.05%↑

PHR.US

8.27

-3.61%↓

MDT

86.15

-0.06%↓

A

114.35

-0.27%↓

VEEV

172.96

-0.65%↓

HQY

83.99

+1.05%↑

PHR.US

8.27

-3.61%↓

MDT

86.15

-0.06%↓

A

114.35

-0.27%↓

VEEV

172.96

-0.65%↓

HQY

83.99

+1.05%↑

PHR.US

8.27

-3.61%↓

Search

Simulations Plus Inc

Abierto

SectorSanidad

12.04 -0.08

Resumen

Variación precio

24h

Actual

Mínimo

11.43

Máximo

12.11

Métricas clave

By Trading Economics

Ingresos

1.4M

676K

Ventas

961K

18M

Rentabilidad por dividendo

0.48

Margen de beneficios

3.67

Empleados

212

EBITDA

-3M

2.3M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+60.74% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.48%

2.45%

Próximas Ganancias

9 abr 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-139M

229M

Apertura anterior

12.12

Cierre anterior

12.04

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

163 / 349 Clasificación en Healthcare

Simulations Plus Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

1 abr 2026, 22:56 UTC

Noticias de Eventos Importantes

Australian PM Set To Announce Interest-Free Loans For Businesses, Farmers

1 abr 2026, 20:50 UTC

Adquisiciones, fusiones, absorciones

Gilead Extends Deadline on Tender Offer to Acquire Arcellx

1 abr 2026, 23:55 UTC

Charlas de Mercado

Gold Rises on Hopes for Early End to U.S.-Iran Conflict -- Market Talk

1 abr 2026, 23:43 UTC

Charlas de Mercado

Nikkei May Rise on Continued Hopes for U.S. Ending Iran War -- Market Talk

1 abr 2026, 23:23 UTC

Noticias de Eventos Importantes

South Korea Consumer Inflation Accelerates on Mideast Energy Shock -- Update

1 abr 2026, 23:07 UTC

Ganancias

Shake Shack Leans on Loyalty Program and Tech to Drive Growth -- Barrons.com

1 abr 2026, 23:02 UTC

Noticias de Eventos Importantes

South Korea Consumer Inflation Accelerates on Mideast Energy Shock

1 abr 2026, 23:00 UTC

Noticias de Eventos Importantes

S Korea Mar CPI +0.3% on Month; +0.6% Forecast

1 abr 2026, 23:00 UTC

Noticias de Eventos Importantes

S Korea Mar Core CPI +2.2% on Year, +0.1% on Month

1 abr 2026, 23:00 UTC

Noticias de Eventos Importantes

S Korea Mar CPI +2.2% on Year; +2.4% Forecast

1 abr 2026, 22:39 UTC

Ganancias

Nike Can't Fix Its China Problem and That's Tanking Its Stock -- Update

1 abr 2026, 22:08 UTC

Charlas de Mercado

KKR BDC Joins Others in Capping Withdrawals at 5% -- Market Talk

1 abr 2026, 22:00 UTC

Noticias de Eventos Importantes

Mideast War Rekindles Asia Inflation Risk, Says DBS Chief Economist -- Interview

1 abr 2026, 22:00 UTC

Noticias de Eventos Importantes

DBS Chief Economist: Rate Hikes Seem Likely in Japan, Singapore, Australia

1 abr 2026, 22:00 UTC

Noticias de Eventos Importantes

DBS Chief Economist: BOK Could Also Take Proactive Approach Like RBA

1 abr 2026, 22:00 UTC

Noticias de Eventos Importantes

DBS Chief Economist: India Vulnerable to War Imapct on Both Trade, Energy

1 abr 2026, 22:00 UTC

Noticias de Eventos Importantes

DBS Chief Economist: China, Malaysia Looks Relatively Well-Insulated From War Fallout

1 abr 2026, 22:00 UTC

Noticias de Eventos Importantes

DBS Chief Economist: Mideast Crisis Won't Hurt Asia Growth Much, Inflation a Bigger Issue

1 abr 2026, 22:00 UTC

Noticias de Eventos Importantes

Inflationary Impact of Mideast Conflict Seems Inevitable, DBS Group Chief Economist Says

1 abr 2026, 21:56 UTC

Adquisiciones, fusiones, absorciones

BHP Completes $4.3 Billion Silver Streaming Agreement With Wheaton Precious Metals

1 abr 2026, 21:31 UTC

Noticias de Eventos Importantes

End to Iran War Could Trigger Relief Rally in These 2 Assets -- Barrons.com

1 abr 2026, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

1 abr 2026, 20:50 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

1 abr 2026, 20:38 UTC

Ganancias

Why Nike Stock Is in 'Penalty Box' After Earnings Beat -- Barrons.com

1 abr 2026, 20:31 UTC

Adquisiciones, fusiones, absorciones

Arsenal Capital Partners Completes Sale of ATP Adhesive Systems to Henkel

1 abr 2026, 20:16 UTC

Adquisiciones, fusiones, absorciones

Gilead: Tender Offer Extended to Expire at 5 p.m. EDT on April 24 >GILD

1 abr 2026, 20:16 UTC

Adquisiciones, fusiones, absorciones

Gilead: Offer Remains at a Purchase Price of $115.00 per Shr >GILD

1 abr 2026, 20:13 UTC

Adquisiciones, fusiones, absorciones

Gilead Extends Tender Offer To Acquire Arcellx >GILD

1 abr 2026, 20:07 UTC

Charlas de Mercado

Mexican Manufacturing Indexes Pick Up in March -- Market Talk

1 abr 2026, 20:07 UTC

Adquisiciones, fusiones, absorciones

Why 2026 Is Biotech's Comeback Year -- Barrons.com

Comparación entre iguales

Cambio de precio

Simulations Plus Inc previsión

Precio Objetivo

By TipRanks

60.74% repunte

Estimación a 12 Meses

Media 19 USD  60.74%

Máximo 19 USD

Mínimo 19 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Simulations Plus Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

4 ratings

2

Comprar

2

Mantener

0

Vender

Sentimiento

By Acuity

163 / 349 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
help-icon Live chat